NCT06750731 Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention Status RECRUITING Phase N/A
NCT06742385 Evaluation of a Remote Monitoring Application in the Follow-up of Patients With Active Inflammatory Bowel Diseases Status RECRUITING Phase NA
NCT06717906 Comparing TRIple Rectal Ultrasound Imaging Technology in Ulcerative Colitis Status COMPLETED Phase NA
NCT06694883 Critical State of "Remission-Recurrence" of Ulcerative Colitis Status RECRUITING Phase N/A
NCT06636656 A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06627556 A Study of Single and Multiple Ascending Doses of H021 in Healthy Participants Status RECRUITING Phase PHASE1
NCT06626165 Association Between Effectiveness of Mirikizumab and UC Patients With High Neutrophilic Infiltration in Epithelium of the Colonic Mucosa Status COMPLETED Phase PHASE4
NCT06625450 TOFACITINIB vs TOFACITINIB WITH MESALAMINE IN ULCERATIVE COLITIS Status NOT_YET_RECRUITING Phase PHASE4
NCT06624579 Prognostic Value of Confocal Endomicroscopy in Ulcerative Colitis: the CONF-UC Study Status NOT_YET_RECRUITING Phase NA
NCT06615765 Acupuncture for Symptom Relief in Adults with Mild to Moderate Ulcerative Colitis Status NOT_YET_RECRUITING Phase NA
NCT06614387 Vedolizumab in Pediatric Ulcerative Colitis- Comparison With Infliximab Status NOT_YET_RECRUITING Phase PHASE3
NCT06609447 The Efficacy and Safety of Combining Probiotic VSL#3 With Vedolizumab for the Treatment of Moderate Ulcerative Colitis Status RECRUITING Phase PHASE4
NCT06598943 A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis Status RECRUITING Phase PHASE2
NCT06595719 Multi-Strain Probiotics Supplementation With Standard Care in Mild to Moderate Ulcerative Colitis Status RECRUITING Phase NA
NCT06587828 A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease Status RECRUITING Phase N/A
NCT06583863 Parasitic Infections and Ulcerative Colitis: Combining Anti-parasitic and Immunomodulatory Treatments May Achieve Remission Status COMPLETED Phase NA
NCT06582264 A Phase 1b Trial to Evaluate the Safety of MB310 in Patients With Active, Mild-to-Moderate Ulcerative Colitis Status COMPLETED Phase PHASE1